Cargando…
Expression of the human molecular chaperone domain Bri2 BRICHOS on a gram per liter scale with an E. coli fed-batch culture
BACKGROUND: The human Bri2 BRICHOS domain inhibits amyloid formation and toxicity and could be used as a therapeutic agent against amyloid diseases. For translation into clinical use, large quantities of correctly folded recombinant human (rh) Bri2 BRICHOS are required. To increase the expression an...
Autores principales: | Schmuck, Benjamin, Chen, Gefei, Pelcman, Josef, Kronqvist, Nina, Rising, Anna, Johansson, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325310/ https://www.ncbi.nlm.nih.gov/pubmed/34330289 http://dx.doi.org/10.1186/s12934-021-01638-8 |
Ejemplares similares
-
Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state
por: Chen, Gefei, et al.
Publicado: (2017) -
Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation
por: Poska, Helen, et al.
Publicado: (2020) -
Functionalization of amyloid fibrils via the Bri2 BRICHOS domain
por: Biverstål, Henrik, et al.
Publicado: (2020) -
The Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ(42) and Alzheimer Amyloid Plaques
por: Dolfe, Lisa, et al.
Publicado: (2018) -
A new kid in the folding funnel: Molecular chaperone activities of the BRICHOS domain
por: Leppert, Axel, et al.
Publicado: (2023)